Steven Helwig
Corporate Officer/Principal presso RADIUS HEALTH, INC.
Posizioni attive di Steven Helwig
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 15/03/2022 | - |
| Comptroller/Controller/Auditor | 26/08/2021 | 15/03/2022 | |
| Direttore Finanziario/CFO | 01/08/2015 | 15/03/2022 | |
| Treasurer | 26/08/2021 | 15/03/2022 |
Storia della carriera di Steven Helwig
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Steven Helwig
- Esperienza
